MyMedR

Displaying 1 publication

Abstract:

Sort:

190TiP: ELUXA 1: Phase II study of BI 1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

Park K, Han JY, Kim DW, Bazhenova LA, Ou SH, Pang YK, et al.

J Thorac Oncol, 2016 Apr;11(4 Suppl):S139.
PMID: 27198328 DOI: 10.1016/S1556-0864(16)30299-4

Filters

Contact Us

Please provide feedback to Administrator ([email protected])

External Links